Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Mol Cell Proteomics. 2012 Apr;11(4):M111.014647. doi: 10.1074/mcp.M111.014647. Epub 2011 Dec 9.
The extracellular matrix (ECM) is a complex meshwork of cross-linked proteins providing both biophysical and biochemical cues that are important regulators of cell proliferation, survival, differentiation, and migration. We present here a proteomic strategy developed to characterize the in vivo ECM composition of normal tissues and tumors using enrichment of protein extracts for ECM components and subsequent analysis by mass spectrometry. In parallel, we have developed a bioinformatic approach to predict the in silico "matrisome" defined as the ensemble of ECM proteins and associated factors. We report the characterization of the extracellular matrices of murine lung and colon, each comprising more than 100 ECM proteins and each presenting a characteristic signature. Moreover, using human tumor xenografts in mice, we show that both tumor cells and stromal cells contribute to the production of the tumor matrix and that tumors of differing metastatic potential differ in both the tumor- and the stroma-derived ECM components. The strategy we describe and illustrate here can be broadly applied and, to facilitate application of these methods by others, we provide resources including laboratory protocols, inventories of ECM domains and proteins, and instructions for bioinformatically deriving the human and mouse matrisome.
细胞外基质 (ECM) 是一种交联蛋白的复杂网格,提供重要的细胞增殖、存活、分化和迁移的生物物理和生化线索。我们在这里介绍了一种蛋白质组学策略,该策略用于使用 ECM 成分的蛋白质提取物富集并随后通过质谱分析来表征正常组织和肿瘤的体内 ECM 组成。同时,我们开发了一种生物信息学方法来预测体内的“基质组”,定义为 ECM 蛋白和相关因子的集合。我们报告了对小鼠肺和结肠的细胞外基质的特征描述,每个组织都包含超过 100 种 ECM 蛋白,并且都呈现出特征性的特征。此外,使用小鼠中的人肿瘤异种移植物,我们表明肿瘤细胞和基质细胞都有助于肿瘤基质的产生,并且具有不同转移潜力的肿瘤在肿瘤和基质衍生的 ECM 成分上存在差异。我们在这里描述和说明的策略可以广泛应用,并且为了方便其他人应用这些方法,我们提供了资源,包括实验室方案、ECM 结构域和蛋白质的清单,以及生物信息学推导人和小鼠基质组的说明。